Company Dynamic-浙江创新生物有限公司

Company Dynamic Home page Company Dynamic

2024-12-10

Mockup Recall

2023-09-05

Daptomycin for Injection,FDA registration. May 18, 2016: A PIND meeting held between Novus and FDA was successfully. The Agency agreed Daptomycin for Injection to be submitted under 505 (b)(2) NDA pathway and also agreed th

2023-02-06

Zhejiang Novus Pharmaceuticals Co., Ltd. was successfully faced the pre-operational visit ( POV) . Zhejiang Novus Pharmaceuticals Co., Ltd. was successfully faced the pre-operational visit (POV) conductedby USFDA to Assess the new technology in sterile manufacturing. This was

2023-02-06

Application project: Vancomycin for Injection On July 08, 2014, A PIND meeting held between Novus and FDA was successfully and the Agency agreed Vancomycin for Injection to be submitted under 505 (b)(2) NDA pathway. After PIND meeting; F

1/1Page

HomePage Prev 1 Next LastPage

HomePage

1/1

LastPage